PB

Pierre van der Bruggen

LR Ludwig Institute For Cancer Research: 5 patents #2 of 52Top 4%
LU Leiden University: 1 patents #1 of 5Top 20%
📍 Brussels, BE: #2 of 77 inventorsTop 3%
Overall (1997): #3,618 of 185,788Top 2%
5
Patents 1997

Issued Patents 1997

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules Thierry Boon-Falleur, Etienne De Plaen, Christophe Lurguin, Catia Traversari, Beatrice Gaugler +1 more 1997-12-09
5686068 Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof Cornelius Melief, M. W. Visseren, Sjoerd Henricus Van Der Burg, Thierry Boon-Falleur 1997-11-11
5683886 Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof Thierry Boon-Falleur 1997-11-04
5629166 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-C-clone 10/MAGE-1 derived peptides, and methods for treating said individuals Thierry Boon-Falleur 1997-05-13
5591430 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre Coulie, Thomas F. Gajewski 1997-01-07